<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02680483</url>
  </required_header>
  <id_info>
    <org_study_id>JoAFR-JCCG</org_study_id>
    <nct_id>NCT02680483</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation Registry in Jordan</brief_title>
  <acronym>JoAFR</acronym>
  <official_title>Atrial Fibrillation Registry in Jordan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jordan Collaborating Cardiology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jordan Collaborating Cardiology Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective registry of all new comers with Atrial fibrillation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      12 tertiary care centers will enroll all AF comers. Details of baseline clinical, EKG, echo,
      and lab data will be documented for all patients. Management is according to the physicians
      discretion. Patients will be followed up for 1 year for clinical endpoints including
      cardiovascular death, stroke, heart failure, systemic embolization and bleeding..
      Anticoagulants and other cardiovascular medications will also be documented.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No interested parties agreed to enroll. Poor enrolling rate. In March 2018, the study was
    terminated.
  </why_stopped>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Incidence of stroke and systemic embolization and cardiovascular death</measure>
    <time_frame>1 year</time_frame>
    <description>all ischemic and hemorrhagic strokes and embolization to any arterial bed during follow up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of readmission for atrial fibrillation</measure>
    <time_frame>1 year</time_frame>
    <description>readmission for atrial fibrillation related problem other than primary such as palpitations, hypotension, syncope, or near syncope.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of readmission for other cardiovascular events</measure>
    <time_frame>1 year</time_frame>
    <description>Atrial Fibrillation in Jordan: risk factors, presentations, in hospital management, long term management, clinical events in hospital and at one year</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>AF cohort</arm_group_label>
    <description>AF consecutive patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All new admissions with atrial fibrillation above the age of 18 or those who develop atrial
        fibrillation during hospitalization for non AF reason.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission with atrial fibrillation

          -  developing atrial fibrillation during hospitalization for mon AF reason.

          -  age 18 or more years.

          -  patients welling to participate in the registry.

        Exclusion Criteria:

          -  age less than 18 years.

          -  patients not welling to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istishari hospital</name>
      <address>
        <city>Amman</city>
        <zip>11954</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2016</study_first_submitted>
  <study_first_submitted_qc>February 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2016</study_first_posted>
  <last_update_submitted>April 1, 2018</last_update_submitted>
  <last_update_submitted_qc>April 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jordan Collaborating Cardiology Group</investigator_affiliation>
    <investigator_full_name>Ayman J. Hammoudeh, MD, FACC</investigator_full_name>
    <investigator_title>Co- investigator with Munir Zaqqa, MD, FACC</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Registry</keyword>
  <keyword>Middle East</keyword>
  <keyword>Jordan</keyword>
  <keyword>risk factors</keyword>
  <keyword>in hospital management</keyword>
  <keyword>long term management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

